Telomeres cap the ends of chromosomes and regulate the replicative life span of human somatic cells. Telomere function is lost upon critical shortening and a p53-dependent checkpoint that detects altered telomere states at the G1/S transition was proposed to act as a regulator of the telomere damage response. We show that telomerase-negative human fibroblasts spend more time in G2 phase as they approach senescence and this delay is associated with manifestations of telomere dysfunction and the triggering of an ATM/ATR-dependent DNA damage signal. This correlates with a partial release of telomeric proteins TRF1 and TRF2. Analysis of the consequences of TRF1 and TRF2 depletion or overexpression of mutated versions revealed that telomere uncapping or telomere replication stress also led to DNA damage signalling in G2. Progression through mitosis of these cells was associated with signs of incomplete telomere terminal processing. We also observed an increase in sister chromatid-type telomere aberrations in senescing fibroblasts indicating that defects of telomere post-replicative events increased as cells age. Our results link a post-replicative damage response at eroded telomeres to G2 arrest signalling and challenge the current paradigm that the checkpoint response to short telomeres occurs primarily at the G1/S transition in human cells.
INTRODUCTION
Telomeres are dynamic nucleoprotein structures that play a critical role in maintaining chromosome stability and cell viability (1) . Human telomeres consist of tandem TT AGGG repeats and end with a 3 0 single-stranded G-rich overhang, which is thought to fold back into the duplex telomere DNA to create the T-loop structure (1, 2) . Key regulators of telomere structure and length include double-stranded (TRF1 and TRF2) and single-stranded (POT1) telomere DNA binding proteins and interconnectors (Rap1, TIN2 and TPP1), which all together form the shelterin complex (2) . Although the shelterin complex shields chromosome ends from unwanted repair activities, it does not render the telomere invisible to the cell surveillance machinery. Rather, it creates a unique identity for the telomere, so that telomeres become transiently uncapped following their replication in S phase and the recruitment of DNA damage repair proteins ensures the correct reassembly of the telomere protective structures in G2 (3, 4) .
Telomere length is maintained by telomerase that offset loss of telomere sequences during DNA replication or nucleolytic processing (5) . However, telomerase activity is absent in most human somatic cells and thus telomeres continuously shorten as cells divide, ultimately leading to loss of telomere function. Normal cells respond to short telomeres by activating the Ataxia Telangiectasia Mutated (ATM)-regulated DNA damage response and initiating replicative senescence (6) (7) (8) . Telomerase expression, which halts telomere erosion, prevents senescence and allows cells to divide indefinitely (9) and consequently, the accumulation of too short telomeres is believed to trigger senescence. However, the precise events that occur at short telomeres remain unclear. Telomere length is probably not the sole factor determining the onset of senescence. Indeed, in most human senescent cells, telomeres are still quite long, often averaging 5-10 kb (5, 10) . Conversely, most of cancer cell lines carry much shorter telomeres yet retain the ability to divide (11, 12) . Moreover, TRF2 over-expression accelerates telomere shortening, resetting the shortest-tolerated telomere length to a lower value, but does not affect the onset of senescence (13) . The delay of senescence is not solely due to inhibition of the senescence signalling pathway by excess TRF2, as telomeres in these cells are also protected from the fusions that would accompany equivalent levels of telomere shortening in cells with normal TRF2 levels. Since, short telomeres per se are not incompatible with continued cell division, a more complex structural determinant or a threshold level of shelterin proteins required to maintain telomere function may be involved (14) .
We hypothesized that eroded telomeres are vulnerable to uncapping during or just after telomere replication. There is evidence that the shortest telomere(s) and not their average length trigger senescence in mouse (15) and that the G2/M cell cycle arrest of senescent yeast cells may be due to a replication problem of the shortest telomere (16) . Replication of both the leading and lagging strands requires the temporarily disruption of the telomere 3D structure by the passage of the replication forks. Loss of telomere sequences due to end-replication problems occurs precisely during this phase of telomere replication at the lagging strand. In addition, telomere ends might be subjected to exonucleolytic attack, which may further exacerbate the instability of critically short telomeres (17) . Unlike chromosome ends with sufficient reserve of telomere repeats and/or telomere binding proteins, a short telomere may not support the formation of a stable conformation after replication. The link between cell cycle progression and telomere uncapping is supported by studies in which shelterin components are inactivated or silenced. For instance, inhibition of TRF2 by a dominant negative allele in human cells or by targeted deletion in mice causes rapid uncapping of telomeres and fusion of chromosome ends via the non-homologous end joining (NHEJ) machinery in both G1 and G2 phases of the cell cycle (18) (19) (20) . Targeted deletion of Trf1 in mice revealed that telomere regions represent fragile sites and require TRF1 for their efficient replication (21, 22) . Upon Trf1 deletion, stalled replication forks accumulate within the telomere repeats, activating a DNA damage response at telomeres that results in senescence in the absence of telomere shortening (21, 22) . Inactivation of shelterin proteins in p53-deficient mouse embryo fibroblasts and immortal cancer cell lines allows mitotic entry in the presence of uncapped telomeres (23) . In such models of telomere dysfunction, some telomere uncapping could be expected on every telomere as opposed to what observed in normal human cells approaching senescence, where telomere uncapping occurs gradually due to the loss of telomeric sequences, resulting in the inability to bind to shelterin components. Little is known about the relationship between the assembly of the post-replicative telomere cap and the cell cycle surveillance machinery during physiological telomere shortening. We investigated here the primary response to telomere shortening in primary human fibroblasts by examining the timing of DNA damage response activation and cell cycle arrest as these cells were losing growth potential. We found that post-replicative eroded telomeres in senescing human fibroblasts recruit DNA damage response factors in G2 and that this telomere damage signalling is associated with p53-dependent delay in G2.
MATERIALS AND METHODS

Cell culture and treatments
WI-38 and IMR-90 fibroblasts were from the American Type Culture Collection. HFF fibroblasts have been described (8) . Cells were cultured in Modified Eagle's Medium supplemented with 10% foetal calf serum (FCS), 1% non-essential amino acids, 1 mM sodium pyruvate, 2 mM glutamine and 100 U/ml penicillin/ streptomycin (GIBCO BRL). Cells were pre-synchronized in G0 by contact inhibition and then released into the cell cycle by dilution. Cells were then arrested at the G1/S boundary by addition of 2 mM hydroxyurea and 12 h incubation, then washed and released in fresh media as described (24) . Caffeine was added at 10 mM for 16 h where indicated.
SA-b-gal staining was carried out as described (8) . The bromodeoxyuridine (BrdU) labelling index was determined by dual immunofluorescence following BrdU incorporation for 1 or 24 h, as described (8) .
Retroviral infection and transfection
Retroviral plasmids used were as follows: TRF1, ÁATRF1, ÁMTRF1, ÁAÁMTRF1 (Flag-tagged), TRF2 and ÁBÁMTRF2 (Myc-tagged) in pLPC vector [described in (13, 18, 25) and gifts from Dr T. de Lange]. pLXSN-HPV-E6/E7 was a gift from D. Galloway. pRETROSuper-shGFP, -shp53 and shATM were gifts from F. D'Adda di Fagagna. Methods used for retroviral production and infection have been described (8) . Infections were performed sequentially and infected cell populations were selected with 400 mg/ml G418 for pLXSN plasmids and 1 mg/ml puromycin for pLPC and pRETROSuper constructs. Retroviral vectors carrying only drug resistance genes were used as controls.
For RNA interference experiments, cells were transfected with 20 nM of siATM, siATR, siTRF1 and siTRF2 SMARTpool and control siGFP (synthesized by Dharmacon) using Oligofectamine (Invitrogen), as described (8) .
Cell fractionation
Cells were suspended in cytoplasmic extraction buffer (CEB) [10 mM HEPES, pH7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 1 mM PMSF, 0.1 mM sodium vanadate, and protease inhibitors cocktail (Sigma)] and incubated on ice for 10 min. Supernatants were collected as cytoplasmic fractions by centrifugation at 1300 g at 4 C for 5 min. Pellets were suspended in nuclear extraction buffer (NEB) (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT, 1 mM PMSF, protease inhibitors) and incubated on ice for 30 min. Supernatants were collected as soluble nuclear fractions by centrifugation at 1700g at 4 C for 5 min. To release chromatinbound proteins, pellets were suspended in NEB with 1 mM CaCl 2 and 0.3 U micrococcal nuclease (Sigma) and incubated at 37 C for 2 min. The insoluble pellet was removed from the chromatin-bound fraction by centrifugation at 13 000g at 4 C for 5 min.
Western-blot analysis
Cells were lysed and analysed by immunoblotting as described (8) . Primary antibodies were as follows: anti-p53 (DO-1), -p21Waf1 (sc-347), -Chk1 (G4), -Cdk2 (sc-163), Cdk4 (sc-260), Cyclin E (HE-12) (Santa Cruz Biotechnology), -S15-p53, -T68-Chk2, -S345-Chk1-S317-Chk1, S1981-ATM (10H11.E12) (all from Cell Signaling Technology), -Chk2 (clone 7, Millipore), -ATM, -ATR, hRap1 (Bethyl Laboratories), -p16INK4a (G175-405), -pRB (G3-245), -Cyclin D1 (G124-326, Bio sciences Pharmingen), Histone H3, g-H2AX (JBW301, Upstate Biotechnology), -TRF2 (4A794, Imgenex), -TRF1 (57-6, Novus Biologicals and TRF-78, Abcam), -POT1 (Novus Biologicals), -TIN2 (gift of S-H Kim, Detroit, USA), -Cyclin A (6E6, Novocastra), -Flag (F-7425), -g-Tubulin (GTU 88) and -a-Tubulin (DM1A) (Sigma). As secondary antibodies, HRP-linked anti-mouse or anti-rabbit (GE Healthcare) were used.
Immunoprecipitation and kinase assay
Cells were lysed and immunoprecipitation was carried out as described (24) , using an anti-Cyclin A (sc-751, Santa Cruz) antibody. Kinase activities were determined by incubating beads with Histone H1 (2 mg, Roche) in kinase reaction buffer (20 mM Tris pH 7.5, 15 mM MgCl 2 ) with 250 mM ATP and 0.2 ml 32 P-g-ATP (10 mCi/ ml) at 30 C for 30 min. Samples were fractionated by SDS-PAGE and gels were stained with Coomassie blue, dried and the Histone H1 bands excised and quantified using a scintillation counter.
ChIP assay
Cells synchronized as above were fixed with 1% formaldehyde for 1 h and ChIP assay was performed as described (8) . Polyclonal anti-TRF1 and anti-TRF2 antibody (for ChIP application, Santa Cruz) and control ChIP grade IgG (Abcam) were used. Real time PCR analysis was performed using the primer sets specific for telomere (26) . PCR amplification conditions were as follows: 10 min at 95 C, followed by 40 cycles of 30 s at 95 C and 2 min at 54 C. Reactions were normalized to the control antibody and fold changes in the levels of association above background was calculated using the following equation Immunofluorescence and telomere fluorescence in situ hybridization (PNA-FISH) Cells grown on coverslips were analysed by immunofluorescence as described (8) at room temperature for 1 min. Chromosomes were counterstained with 0.1 mg/ml Hoechst.
Terminal restriction fragment (TRF) length analysis
Genomic DNA was extracted using the DNeasy Tissue kit (Qiagen). A total of 3 mg were digested with HinfI and RsaI and resolved by 0.7% Tris-acetate-EDTA agarose gel electrophoresis. Telomere fragments were detected by Southern blotting with a single-stranded (CCCTAA) 3 telomeric probe and autoradiography. Autoradiographs were scanned with a densitometer and the mean telomere length was determined by quantifying the smear of hybridized fragments with the Molecular Analyst software (Bio-Rad) and an Excel spreadsheet designed to calculate the mean telomere length using the formula described in (5).
Image acquisition and image deconvolution
Images were captured with a DMRA Leica epifluorescence microscope, a plan apochromat Â100 oil objective (numerical aperture 1.4) and a 12 bits CoolSnap HQ2-cooled charge-coupled device camera (Photometrics, Tucson AZ) driven by the Metamorph 7.1 software (Universal Imaging Corporation). Nuclear size was quantified from digital images using the Metamorph advanced measure module.
Images were collected at 500 nm z-intervals from a series of 10 focal planes for the red and green channels. Images were processed using the classic maximum likelihood estimation algorithm of the Huygens professional software (Scientific Volume Imaging BV, Hilversrum, The Netherlands). Deconvolved images were imported into the Imaris program (Bitplane AG, Zurich, Switzerland) where PNA focal volumes were determined by generating 3D reconstructions under Surpass. The section with the largest volume area (presumed middle of the dot) was used for quantitative analysis. Images were pseudocoloured with Metamorph 7.1.
Statistical analyses
The statistical significance between means was assessed with the unpaired Student's two-tailed t-test, with P < 0.01 considered as statistically significant.
RESULTS
Short telomeres trigger a DNA damage response during G2 phase
Foci of phosphorylated H2AX (g-H2AX) are markers of the ATM and ataxia telangiectasia and Rad3-related (ATR)-regulated DNA damage responses, but they are also associated with dysfunctional telomeres, including short (6-8), unprotected (28) and damaged (21, 22) telomeres. To investigate the timing of g-H2AX recruitment to telomeres during replicative aging of human primary foreskin fibroblasts (HFF), we determined BrdU incorporation, telomere length and g-H2AX telomere dysfunctioninduced foci (TIFs) formation in individual cells using immunofluorescence and telomere PNA-FISH. g-H2AX began to be recruited to telomeres very early, when telomeres started to shorten and accumulated as far as 10-20 population doublings (PDs) away from full senescence at PD87 ( Figure 1A ). The PNA-FISH data correlated well with the results obtained using terminal restriction fragment (TRF) length analysis, an independent technique that does not rely on fluorescence, but on Southern-blot analysis of restriction enzyme-digested genomic DNA (see 'Materials and Methods' section) (P = 0.0001) (Supple mentary Figure S1 ).
Quantification of the number of TIF-positive cells throughout the cell cycle indicated that, pre-senescent (PD70) fibroblasts were enriched in TIFs in the G1 and G2 phases, but rarely in mitotic cells ( Figure 1B ). The telomeric damage signal observed in G1 pre-senescent cells highlighted a subpopulation of cells that are undergoing early senescence. Indeed, the BrdU labelling index in pre-senescent cultures decreased to 35%, and 25% of the cells displayed b-galactosidase activity at pH 6 (SA-bGal; a biomarker of senescence) [ Figure 1A and data not shown; see also (8)]. To make sure that tetraploid pre-senescent cells in the G1 phase of the cell cycle were not included in the G2 population based on their DNA content, we evaluated also the expression of Cyclin A, a S/G2 marker. Most of the cells that displayed high levels of Cyclin A contained also many TIFs ( Figure 1C and D), arguing against the possibility that G1-arrested tetraploid cells were included in the G2 group.
TIFs accumulation in G2 in pre-senescent cells might be the result of damage due transient uncapping of telomeres following replication (3) in line with the immunofluorescence data in young cells ( Figure 1B ) or it could be due to short telomeres that persist uncapped during or after replication. Therefore, we assessed whether g-H2AX accumulation was related to telomere length in pre-senescent fibroblasts using telomere PNA-FISH and dual immunofluorescence to detect g-H2AX and Cyclin A in the same preparation. On the basis of the PNA-FISH signal intensity, we found that among the Cyclin A-positive cells, those with shorter telomeres showed a higher incidence of telomeric g-H2AX staining (Figure 2A and B), as indicated also by the significant negative correlation (P < 0.0001) between telomeric g-H2AX staining and telomere fluorescence intensity ( Figure 2C ). We therefore conclude that the incidence of telomeric g-H2AX staining in G2 phase of pre-senescent cells relative to young cells arise from short telomeres that might have remained dysfunctional during or after their replication and were more prone to remain uncapped.
Next, we tested whether the increased telomeric damage observed in pre-senescent fibroblasts during G2 could lead to activation of the DNA damage machinery. Cells at PD69 showed activation of key molecules involved in the DNA damage response, such as phosphorylation of ATM on Ser 1981 and its target checkpoint kinases Chk2 (on Thr 68) and Chk1 (on Ser 317) in G2/M phase ( Figure 2D ). Conversely, phosphorylated Chk2 and Chk1 kinases were not detected in young cells (PD25) in G2/M ( Figure 2D ), consistent with the notion that in young cells the DNA damage response is activated only locally at telomeres in G2 to promote the reassembly of a protective structure in newly replicated telomeres (3, 4) .
Persistence of TIFs in G2 is associated with reduced TRF1 and TRF2 binding
To assess whether g-H2AX accumulation was linked to changes in telomere chromatin, we performed quantitative real-time PCR for telomere repeats following chromatin immunoprecipitation (ChIP) of cross-linked chromatin of young and pre-senescent HFF cells (26) . We compared TRF1 and TRF2 occupancy of telomeres and found reduced binding of both proteins in pre-senescent HFF cells ( Figure 2E ). Western blotting confirmed that comparable levels of immunoprecipitated TRF1 and TRF2 were retrieved following the ChIP assay among the different conditions (Supplementary Figure S2B) . Next, we inhibited TRF1 and TRF2 function at telomeres to evaluate whether the persistence of TIFs in G2 was indicative of telomere protection dysfunction. Similar results were obtained either by generating stable cell lines with constructs that encode dominant negative TRF1 and TRF2 mutants, which lack the Myb DNA binding domain (ÁMTRF1 and ÁBÁMTRF2) (13, 25) or by transfection of siRNAs against TRF1 and TRF2. The number of cells containing g-H2AX foci increased significantly in cells with impaired TRF1 and TRF2 function relative to control cells ( Figure 3A ). Up to 60% of the g-H2AX signal co-localized with telomeres as indicated by telomere PNA-FISH, in cells in which TRF1 (ÁMTRF1 or siTRF1) or TRF2 (ÁBÁMTRF2 or siTRF2) activity was inhibited ( Figure 3B ). TIF induction was accompanied by phosphorylation of Chk1 on Ser 345, the preferential target for phosphorylation by ATR kinase (29) , in cells expressing ÁMTRF1 or ÁBÁM TRF2 (although less prominent) ( Figure 3C ). Conversely, ÁBÁMTRF2-expressing cells showed preferential phosphorylation of ATM and Chk2 ( Figure 3C ). This difference was not due to different levels of DNA damage activation at telomeres because TIFs formation was comparable in ÁMTRF1-and ÁBÁMTRF2-expressing cells ( Figure 3B ). Finally, to determine which fraction of cells formed g-H2AX foci, we performed a detailed cell-cycle analysis and found that TIFs induction occurred mainly in cells in S/G2 phases at early time points after TRF1 and TRF2 knockdown with siRNAs ( Figure 3D ). Telomere uncapping, rather than shortening, probably accounted for the observed phenotypes because telomere length did not seem to be altered in early passage ÁMTRF1 and ÁBÁMTRF2 cells (Supplementary Figure S3A) . Therefore, TRF1 or TRF2 inhibition might switch telomeres to a senescence-signalling state by disrupting the shelterin complex. Although POT1, TIN2 and TRF2 expression in whole-cell lysates appeared unaltered by immunoblotting, they were severely depleted from the chromatin-bound fraction in ÁMTRF1 cells (Supplementary Figure S3B and S3C) . In contrast, the amount of hRap1 recovered in the chromatin-bound fraction was unaltered (Supplementary Figure S3B) . Immunofluorescence analysis confirmed that ÁMTRF1 expression led to loss of the punctuated telomeric signal of POT1, TIN2 and TRF2 (Supplementary Figure S4) . These results suggest that TRF1 inhibition hinders TRF2 accumulation at chromosome ends and affects POT1 and TIN2 accumulation at telomeres, consistent with their dependence on TRF1 for telomere . Shown is the percentage of cells with more than three foci in which g-H2AX co-localized with telomere (TIFs). Statistical significance compared with controls (vector alone or siGFP) was assessed with the Student's t-test (**P < 0.001). Western blot of TRF1 and TRF2 expression in siGFP (control), siTRF1 or siTRF2-transfected HFF is shown (lower panel). (C) Immunoblot analysis of ATM, Chk2 and Chk1 phosphorylation in WI-E6/E7 cells expressing the indicated retroviral plasmids. Cells were analysed at day 8 after infection. Blots were probed for S1981-ATM, ATM, T68-Chk2, Chk2, S345-Chk1 and Chk1 expression. g-Tubulin served as loading control. ÁATRF1 is a mutant of TRF1 that lacks the TRF1 acidic domain. ÁAÁMTRF1 is a dominant-negative mutant of TRF1 that lacks both the Myb DNA binding and acidic domains. (D) Quantification of TIF-positive cells following transfection with siTRF1, siTRF2 or siGFP. Cells were immunolabeled with anti-g-H2AX and anti-CyclinA antibodies 48 h after transfection. Cyclin A is expressed throughout the S and G2 phases of the cell cycle and was used as a marker to identify cells in the S/G2 phase. Telomeres were detected by PNA-FISH. Fifty cells were analysed per condition in two independent experiments. binding (2) . Although hRap1 expression in whole-cell lysates appeared unaltered by immunoblotting (Supple mentary Figure S3D ), expression of ÁBÁMTRF2 led to a significant loss of hRap1 from telomeres as shown by cell fractionation and immunofluorescence experiments, consistent with its dependence on TRF2 for telomere binding (Supplementary Figures S3B and S4) . In contrast, the amount of TRF1, TIN2 and POT1 recovered in the chromatin-bound fraction was unaltered (Supple mentary Figure S3B) .
These results show that telomere proteins are required for efficient capping of telomeres in the G2 phase of the cell cycle. Higher occurrence of TIFs in G2 in presenescent fibroblasts may therefore reflect the fact that shorter telomeres are more prone to remain uncapped after replication.
Telomere capping is monitored in G2 by the ATM-and ATR-dependent damage responses
To test the role of ATM and/or ATR in monitoring telomere integrity, we monitored TIFs formation upon ATM and/or ATR inhibition in cells over-expressing ÁMTRF1 or ÁBÁMTRF2 and in which telomeres are deprotected. Treatment with the PI3K inhibitor caffeine completely blocked TIF induction in these cells, indicating that telomere damage signalling involves ATM and/or ATR kinases (Supplementary Figure S5A and S5B ). In addition, the knock down of ATR or ATM by RNA interference experiments (Supplementary Figure S5C) showed that ATR was involved in H2AX phosphorylation following ÁMTRF1 over-expression, whereas both ATM and ATR (to a lesser extent) could play a role in the damage response following ÁBÁMTRF2 over-expression (Supplementary Figure S5A and S5B) .
To further test the importance of the ATM and ATR pathways in the activation of the DNA damage response in G2, we monitored g-H2AX and 53BP1 (another mediator of the DNA damage response) foci formation at telomeres, upon inhibition of ATM and ATR in pre-senescent cells. Inhibition of both ATM and ATR by caffeine decreased significantly g-H2AX and 53BP1 foci formation at telomeres (Figure 4) . The knockdown by siRNA of ATR and particularly of ATM markedly reduced the percentage of TIF-positive pre-senescent cells in G2 ( Figure 4A and C) . These data indicate that, in pre-senescent fibroblasts, telomere dysfunction in G2 triggers the full activation of both the ATM-and ATR-DNA damage response. Figure S6D) . To evaluate whether p53 and pRB play a role in preventing mitotic entry of cells with persistent uncapped telomeres in G2, early passage cells were infected with retroviruses expressing HPV16-E6/E7 (E6/E7 cells), two viral oncoproteins known to inhibit these tumour suppressors and then with retroviruses expressing ÁMTRF1 or ÁBÁMTRF2. E6 and E7 expression allowed bypassing the growth arrest and senescence phenotype due to ÁMTRF1 or ÁBÁMTRF2 expression (Supplementary Figure S6E) . This facilitated the isolation of metaphase chromosomes, which could not be done in cells expressing only ÁMTRF1 or ÁBÁMTRF2 due to the low number of mitotic cells and the analysis of the fate of uncapped telomeres during mitosis by telomere PNA-FISH. ÁMTRF1 or ÁBÁMTRF2 over-expression in E6/E7 cells resulted in increased frequency (4-to 5-fold and 10-to 14-fold, respectively, P < 0.0001) of sister chromatid fusions compared to empty vector controls and E6/E7 cells over-expressing TRF1 and TRF2 ( Figure 5A and B) . On an average, metaphases isolated from control IMR-E6/E7 and HFF-E6/E7 cells displayed 0.04 and 0.10 events, respectively ( Figure 5B ). Moreover, in most cells with sister chromatid fusions, telomere DNA was detected ( Figure 5A, panel b) , indicating that such events occurred in the absence of total telomere deletion (31) . E6/E7 cells over-expressing ÁMTRF1 or ÁBÁMTRF2 also showed a significant increase in chromosome ends with multi-telomeric signals [MTS, characterized by the presence of an extra-telomeric signal at one chromatid end ( Figure 5A , panel c and C)], which is a direct indicator of telomere fragility resulting from replication fork stalling within the telomeric sequences (21, 22) . In addition, sister telomere losses [loss of telomere signal at only one chromatid end ( Figure 5A, panel d) (32) ] and telomere deletions [lack of telomere signals at both sister chromatids ( Figure 5A, panel e) ], but not end-to-end chromosome fusions (dicentric) ( Figure 5A , panel f), were increased in E6/E7 cells expressing ÁMTRF1 (Figure 5D-F) . Sister telomere loss and telomere deletion are thought to result from replication-associated telomere defects. Specifically, sister telomere loss might arise from S-or G2-specific post-replicative defects that affect only a single chromatid, whereas telomere deletion might be due to pre-replicative telomere dysfunction copied during S phase. Conversely, in E6/E7 cells expressing ÁBÁMTRF2 the frequencies of sister telomere losses and telomere deletions did not change appreciably relative to controls, whereas the frequency of dicentric chromosomes increased between 16-and 25-fold (P < 0.0001; Figure 5D -F). This suggests that dicentric chromosomes produced by TRF2 inhibition may instead reflect telomere uncapping (31) . Therefore, our results suggest that in human primary fibroblasts, p53 and pRb block mitotic entry until all telomeres are properly processed in G2 to prevent telomere-dependent chromosomal abnormalities.
We have also observed an increase in sister chromatid-type telomere aberrations in pre-senescent HFF and IMR-90 cells whereas sister chromatid fusions and chromosome fusions were exceedingly rare or not present at all (Figure 6 ). Sister telomere losses were the most frequent telomere aberrations in pre-senescent cells and the percentage of chromosomes ends with multi-telomeric signals and terminal deletion increased in pre-senescent compared to younger cells ( Figure 6B ), indicating that defects of telomere post-replicative events increased with age. Therefore, telomere instability leading to DNA damage response in G2 in pre-senescent cells is distinct from telomere dysfunction that results in chromosome end-to-end fusions.
Extended G2 phase in pre-senescent fibroblasts is associated with p53 activation Since DNA damage signalling in G2 in normal cells leads to cell cycle arrest, which is mainly triggered by the p53 pathway (24), we investigated p53 activation by monitoring the accumulation of the Cdk inhibitor p21, a p53 transcriptional target, in aging fibroblasts. p21 accumulation started very early, at PD73 many PDs before senescence ( Figure 7A) . Coincident with the increase in p21 levels, the ratio of hyperphosphorylated pRB to dephosphorylated pRB decreased very early at PD73 (Figure 7A ), suggesting that p21 targets proteins regulated by the activity of Cdks. We first compared the expression of various cell cycle proteins between young proliferating, pre-senescent and fully senescent fibroblasts (no growth potential left). We found that the levels of Cyclin D1, A and E, Cdk2, Cdk4 and p16 were essentially unchanged at PD73 while the expression patterns of Cyclins and Cdk2 were altered in fully senescent cells (PD87). No significant changes in the levels of Cdk4 and Cdk6 were observed in HFF cells of any age ( Figure 7A and data not shown). The changes in Cyclin D1, A and E levels, however, correlated with p16 accumulation whereas p21 expression peaked at PD82 (BrdU labelling index <10%) and declined thereafter in fully senescent cells, although its level remained higher than in young cells ( Figure 7A ).
As Cyclin A/Cdk activation can be blocked by ATM/ ATR kinases signalling through p53-mediated up-regulation of p21, which directly inactivates Cyclin/ Cdk complexes, we next analysed the Cyclin A-associated kinase activity, which controls S-phase progression and contributes to the G2/M transition entry (33) (34) (35) , with an immunoprecipitation-kinase assay using Histone H1 as substrate. We found that the Cyclin A-associated kinase activity was markedly reduced in PD69 cells ( Figure 7B ) concomitantly with the increase in p21 levels ( Figure 7A ). Although Cyclin A remained associated with Cdk2 in pre-senescent cells, Cyclin A complexes contained increased levels of p21 as indicated by co-immunoprecipitation experiments, in comparison to young cells ( Figure 7C ). These changes are consistent with the prolonged S/G2 phase of pre-senescent compared to young cells ( Figure 7D ). Knockdown of p53 by shRNA in cells at PD69 resulted in significant increased Cyclin A-associated kinase activity and reduction of nuclear colocalization of p21 and Cyclin A ( Figure 7B , C and E). Similar effect but to a lesser degree was obtained by shRNA-mediated knockdown of the ATM kinase ( Figure  7B , C and E). These data confirm the involvement of the ATM kinase in sensing telomere damage and suggest that p21 acts downstream of p53 in response to telomere dysfunction in G2 in human fibroblasts.
DISCUSSION
Short telomeres or defects in telomere proteins can activate a checkpoint response that results in cell cycle arrest or apoptosis depending on the cellular background (6) (7) (8) 36, 37 ). An ATM-and p53-dependent checkpoint that detects altered telomere states at the G1/S transition was proposed to act as a regulator of the cellular response to telomere damage (37) . Here we provide evidence that telomere shortening over successive cell divisions triggers a p53-dependent G2 checkpoint response that involves the ATM and ATR-dependent DNA damage signalling pathways. At each cell cycle, during a short time window, functional telomeres can be perceived and treated as double-strand breaks (DSB), thus rendering them temporarily dysfunctional, as evidenced by the transient recruitment of DNA damage sensors and repair proteins (3). These factors initiate the reactions required for telomere elongation, processing and capping (3) as well as reactions related to DNA repair by homologous recombination needed for the assembly of new functional telomeres (4). Telomere proteins should limit the duration of such telomere processing to a narrow interval just after conventional replication had been completed. We propose that, in the absence of telomerase, chronic telomere shortening and the concomitant imbalances of telomere proteins that occur in senescing cells affect proper telomere replication and end-protection. Short telomeres might thus be more prone to persist in an uncapped state and to trigger the p53-dependent G2 checkpoint response. In such cells, the ATM/ATR kinases, which are sensors of open telomere states, are activated and p53 acts as an effector to delay mitotic entry and halt the cell cycle in a state that favours the re-establishment of post-replicative telomere endprocessing and protection. Our results suggest that aging fibroblasts suffer from post-replicative telomere damage owing to telomere shortening. Unlike chromosome ends with adequate telomere length, in which DNA damage occurs transiently during the G2 phase of the cell cycle, in aging cells, damage would persist at a subset of the shortest telomeres, activating a full DNA damage response. The ability of TRF2 and possibly of other telomere proteins to participate in the telomere protective structure formation and stabilization (4, 38, 39) suggests that these proteins are required to ensure telomere integrity in the G2 phase after replication. Here, we show that telomere dysfunction through inhibition of TRF1 or TRF2 function leads to persistence of TIFs in G2, implying that down-regulation or functional imbalance of these proteins could account for telomere deprotection in G2 despite the presence of long telomeres. In addition, the threshold abundance of telomere proteins required to block chromosome fusions must be lower than the levels required for repressing the DNA damage response. This is supported by the observation that cells expressing ÁMTRF1, despite showing a DNA damage response at chromosomes ends, fail to exhibit massive chromosomal end-to-end fusions. This finding implies that in such cells, the chromosome ends maintain the capacity to suppress fusions through the retention of sufficient shelterin components, such as TRF2, to block the NHEJ pathway. Conversely, TRF2 inhibition in cells expressing ÁBÁMTRF2 led to fully uncapped telomeres, resulting in chromosome fusions. In such cells, the fusogenic state would arise because chromosome ends do not retain sufficient levels of shelterin to block the NHEJ pathway. Thus, in pre-senescent cells, the DNA damage response in G2 may result from insufficient levels of shelterin proteins; however, sufficient telomere protection is retained to prevent NHEJ as the frequency of chromosome fusions is rare in aging fibroblasts.
The observed telomere DNA damage response might also reflect abnormalities in stalled or collapsed replication forks, which can induce the ATR-H2AX/Chk1 signalling cascade, followed by DSB formation and consequent activation of the ATM-H2AX/Chk2-p53 pathway (29, 30) . Telomere proteins facilitate replication fork movement along the telomere and are critical to ensure faithful replication of telomeres (40) . For example, TRF1 and TRF2 interact with and stimulate the RecQ-like helicases BLM and WRN (21, 41, 42) , suggesting that they recruit these proteins to enable efficient replication and/or repair at the telomeres. It is not yet clear why short telomeres would be sensitive to replication fork progression, although one possibility is that chromatin changes at shortened telomeres (43) might contribute to increased replication stalling and thus stretch of single-stranded DNA formation. Upon ÁMTRF1 expression, chromosomes showed an increased frequency of chromatid aberrations, which might be due to defective telomere replication. Indeed, multi-telomeric signals result from incomplete replication or processing of stalled forks, leading to altered packaging and/or condensation of chromatin due to extended areas of single-stranded DNA, as suggested for fragile telomeres (21) . This is in agreement with the hypothesis that alteration in the composition of the shelterin complex interferes with terminal processing.
Our data reveal that senescing cells spend an increasing amount of time in G2. Perhaps, a single defective (but not critically short) telomere is sufficient to activate a transient G2 checkpoint arrest signal and, as more telomeres become defective, this signal exceeds a damage threshold, resulting in a progressively prolonged G2 arrest. It is conceivable that the initial adaptation to this extended G2 phase allows cells to avoid NHEJ for completing the processing of telomere ends before proceeding with the cell division. In this case, the transient arrest would not be expected to block the growth of cells. However, the use of NHEJ to repair multiples post-replicative dysfunctional (critically uncapped short) telomere ends would lead to telomere fusions that allow cells to overcome the checkpoint arrest and eventually to progress to G1, where the permanent cell cycle arrest and senescence program will be engaged in response to breaks induced by chromosome fusions following mitosis. Alternatively, the persistence of physiologically uncapped telomeres in G2 may send a qualitatively different signal that results in arrest during the next cell cycle. Our findings challenge the current paradigm that the checkpoint response to eroded telomeres occurs primarily at the G1/S transition in human cells. The insert shows the distribution of the length (hours) of the S/G2 phase in 15 analyses for each culture (**t-test P-value <0.001). (E) Quantification of co-expression of Cyclin A and p21 in nuclei of young and pre-senescent HFF cells expressing the indicated shRNAs. Cells were analysed 8 days post-infection by double-immunofluorescence for Cyclin A and p21 expression. The mean (±SD) of three independent experiments is shown (*t-test P-value <0.01; **P < 0.001).
